Paasa Logo
Addex Therapeutics Ltd logo
ADXNSIXMarket closedOpens 9:00am CET

Addex Therapeutics Ltd

CHF 0.02Last updated
-CHF 0.00 (11.38%)Past day
Timezone

Addex Therapeutics Ltd (SIX: ADXN) is trading at CHF 0.02, about ₹3 at today's CHF/INR rate, as of 28 Sep 2026, 11:35 AM ET, down 11.38% today. Indian residents can buy Addex Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:CHF 0.03
Previous close:CHF 0.02
Volume:1.69M

Today's low

CHF 0.02

Today's high

CHF 0.03

52 week low

CHF 0.02

52 week high

CHF 0.07

ADXN opened at CHF 0.03, closed previously at CHF 0.02, and has traded between CHF 0.02 and CHF 0.07 over the past 52 weeks.

About

Addex Therapeutics Ltd, a biopharmaceutical company in its development phase, specializes in the discovery, progression, and commercialization of small-molecule pharmaceutical products designed to address central nervous system (CNS) conditions. Based in Geneva, Switzerland, the firm's core research centers on identifying oral small molecule allosteric modulators that interact with G-protein coupled receptors. Its leading clinical programs feature Dipraglurant, intended for the treatment of levodopa-induced dyskinesia in Parkinson's disease and dystonia; ADX71149, targeting epilepsy and various other neurological disorders; and GABAB PAM, developed to combat addiction. Addex has established strategic licensing and collaborative partnerships with organizations including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002, the company changed its name from Addex Pharmaceuticals Ltd to its current designation in March 2012.

Country
CH
CEO
Timothy Mark Dyer
Exchange listed on
SIX
Industry
Biotechnology
Base currency
CHF
Full Time Employees
3
Sector
Healthcare
IPO date
22/05/2007

Key statistics

Avg. volume

583.48K

Market cap

CHF 3.31M

P/E Ratio

-0.39

Price-to-sales ratio

36.95

Enterprise value

CHF 2.48M

Free cash flow yield

-70.63%

Debt-to-equity ratio

0.03

Return on equity

-131.35%

ROIC

-74.38%

Beta

1.96

Dividend yield

0.00%

Last dividend

CHF 0.00

Financial overview

Revenue

CHF 173.00K

Earnings per share

-CHF 0.06

Free cash flow

-CHF 2.17M

Net profit margin

-7775.20%

Gross margin

84.32%

EBITDA

-CHF 2.81M

Revenue growth

-57.81%

Similar securities

This is not an investment recommendation

How to buy Addex Therapeutics from India

Indian residents can buy Addex Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to CHF.

  3. Search for Addex Therapeutics and place an order

    Find Addex Therapeutics by name or by its ticker, ADXN, and choose an order type. Addex Therapeutics trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Addex Therapeutics position in CHF and INR. Addex Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Addex Therapeutics from India

Trading and taxes when buying Addex Therapeutics from India

Trading and limits

Trading hours
9:00 am – 5:30 pm CET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneAddex Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Addex Therapeutics stock?

Yes. Addex Therapeutics (ADXN) has been listed on the SIX Swiss Exchange since 2007, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to CHF. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Addex Therapeutics share cost in rupees?

One Addex Therapeutics share is CHF 0.02 — about ₹3 at a CHF/INR rate of 115.72 on 27 Sep 2026. Both the Addex Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Addex Therapeutics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on Addex Therapeutics shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the CHF/INR rate on the purchase and the sale date, so the rupee move counts alongside the Addex Therapeutics price. Paasa issues a capital-gains statement for your return.

Does Addex Therapeutics pay a dividend?

No. Addex Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Addex Therapeutics from India?

The SIX Swiss Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Switzerland is on standard time. Orders can only execute during that window.

Do I have to declare Addex Therapeutics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Addex Therapeutics holding, its cost and its closing value.

How do I sell Addex Therapeutics and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in CHF in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.

Does the rupee rate affect what I make on Addex Therapeutics?

Yes. Addex Therapeutics is priced in CHF, so your rupee outcome combines the CHF move with the CHF/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.